CCT2 and neuroblastoma: While investigations into the expression and role of CCT2 in human malignancies are somewhat limited, upregulated CCT2 expression has been documented in various cancers, including neuroblastoma, colon cancer, and small cell lung cancer, and is correlated with an unfavorable prognosis [7–9].